磷酸甘露糖异构酶 (PMI/MPI)、磷酸甘露糖变位酶 (PMM) 和 GDP-Man 焦磷酸化酶 (GMPP) 是参与 GDP-Man 生物合成的三种关键酶,而 GDP-Man 是细胞壁甘露聚糖生物合成和蛋白质糖基化所必需的。UDP-glucose (UDP-Glc)、UDP-GlcNAc 和 GDP-Man 是细胞壁生物合成所需的三种前体。PMI 催化果糖-6-磷酸 (Fru6P) 和甘露糖-6-磷酸 (Man6P) 之间的转化[1]。这种酶存在于哺乳动物、细菌和真菌中,在细胞壁合成、活力和细胞信号传导中起重要作用。PMI 缺乏与先天性糖基化障碍 (CDG) 有关。 PMI 抑制剂与甘露糖补充相结合可能有助于 N-糖基化正常化,并改善 CDG-Ia 病理情况[2]。
Phosphomannose isomerase (PMI/MPI), phosphomannose mutase (PMM), and GDP-Man pyrophosphorylase (GMPP) are the three crucial enzymes involved in the biosynthesis of GDP-Man, which is required for cell wall mannan biosynthesis and protein glycosylation. UDP-glucose (UDP-Glc), UDP-GlcNAc, and GDP-Man are the three precursors required for cell wall biosynthesis. PMI catalyzes the conversion between fructose-6-phosphate (Fru6P) and mannose-6-phosphate (Man6P)[1]. This enzyme is present in mammals, bacteria, and fungi and plays an important role in cell wall synthesis, viability, and cell signaling. PMI deficiency is associated with congenital disorder of glycosylation. PMI inhibition combined with mannose supplementation might help normalize N-glycosylation and improve CDG-Ia pathology[2].
α-D-Glucose 1,6-bisphosphate 是一种 PMM2 和磷酸葡萄糖变位酶激活剂,可调控糖原代谢、糖酵解、氨基糖合成以及细菌细胞壁与荚膜的形成,并可用于 pmm2-cdg(cdg-1a 或 Jaeken 综合征)的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号